Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling

DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG

(2020) Omprakash Shriwas et al.   APOPTOSIS

lncRNA MEG3 modified epithelial‐mesenchymal transition of ovarian cancer cells by sponging miR‐219a‐5p and regulating EGFR

(2019) Lei Wang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis

(2018) Junrong Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown

(2018) Hachung Chung et al.   CELL

Functional Classification and Experimental Dissection of Long Noncoding RNAs

(2018) Florian Kopp et al.   CELL

Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells

(2018) Juan Xu et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Physical interaction of STAT1 isoforms with TGF-β receptors leads to functional crosstalk between two signaling pathways in epithelial ovarian cancer

(2018) Xiaoling Tian et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer

(2018) Yiran Liang et al.   Cell Death & Disease

LncRNA BANCR promotes tumorigenesis and enhances adriamycin resistance in colorectal cancer

(2018) Siping Ma et al.   Aging-US

Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p

(2018) Changhong Wang et al.   Journal of Gynecologic Oncology

Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer

(2018) Wu Yong et al.   Cell Death & Disease

RNA m6 A modification enzymes shape innate responses to DNA by regulating interferon β

(2018) Rosa M. Rubio et al.   GENES & DEVELOPMENT

Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer

(2018) Chong Qu et al.   OncoTargets and Therapy

Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9

(2017) Lianghai Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer

(2017) Mary R. Doherty et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Transcriptional Regulation of Antiviral Interferon-Stimulated Genes

(2017) Wenshi Wang et al.   TRENDS IN MICROBIOLOGY

LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194

(2017) Jihong An et al.   OncoTargets and Therapy

Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3

(2017) Yin-ling Xiu et al.   Oncotarget

CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response

(2017) Abdul S. Qadir et al.   Cell Reports

UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy

(2016) Ling Zhang et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer

(2016) Qing Chen et al.   NATURE

The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer

(2016) Jun‑jun Qiu et al.   Oncotarget

Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer

(2015) Marie-Emmanuelle Legrier et al.   BRITISH JOURNAL OF CANCER

Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer

(2015) JUN-JUN QIU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

DDX3, a potential target for cancer treatment

(2015) Guus Martinus Bol et al.   Molecular Cancer

Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy

(2015) E Lau et al.   ONCOGENE

B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway

(2014) T-S Wu et al.   ONCOGENE

DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway

(2014) H-H Chen et al.   ONCOGENE

Expression Signature of IFN/STAT1 Signaling Genes Predicts Poor Survival Outcome in Glioblastoma Multiforme in a Subtype-Specific Manner

(2012) Christine W. Duarte et al.   PLoS One

HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer

(2011) E. A. Stronach et al.   CANCER RESEARCH

DDX3 Regulates Cell Growth through Translational Control of Cyclin E1

(2010) M.-C. Lai et al.   MOLECULAR AND CELLULAR BIOLOGY

Identification of an antiapoptotic protein complex at death receptors

(2008) M Sun et al.   CELL DEATH AND DIFFERENTIATION

The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response

(2008) Didier Soulat et al.   EMBO JOURNAL

Human DDX3 functions in translation and interacts with the translation initiation factor eIF3

(2008) C.-S. Lee et al.   NUCLEIC ACIDS RESEARCH